DaVita's presentations at ADC: New developments in the field of CKD, Vascular Access and Home Modalities

DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), in conjunction with DaVita Clinical Research®, today announced that company representatives will present 20 presentations at the 30^th Annual Dialysis Conference (ADC) scheduled for March 6 – 9 in Seattle.

“Our continued dedication to the relentless pursuit of quality and improvement in care delivery benefits the patients we serve in our outpatient dialysis and acute dialysis facilities.”

ADC provides a forum for an international group of practitioners and researchers to discuss current developments in the field of dialysis. It is a platform for the nation’s leading renal health care providers to learn about new developments in the field of nephrology and CKD care.

“DaVita is proud to present high quality clinical research to the top kidney care providers in the industry,” said Allen R. Nissenson, MD, FACP, Chief Medical Officer for DaVita®. “Our continued dedication to the relentless pursuit of quality and improvement in care delivery benefits the patients we serve in our outpatient dialysis and acute dialysis facilities.”

At this year’s ADC, DaVita will focus on several key research initiatives in the areas of CKD, Vascular Access, and Home Modalities. Highlights from these scheduled presentations include:

• Title: Patient Characteristics and Factors Influencing the Choice of PD
  Presenter: John Moran, MD

• Title: Impact of Phosphorus Additives on ESRD Care
  Presenter: Kamyar Kalantar-Zadeh, MD

• Title: Identifying Common Causes and Practical Solutions for Decreasing Central Vein Catheter Dependence for Hemodialysis Access
  Presenter: Mary Isambert